Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

Jill S. Goldman, Susan E. Hahn, Jennifer Williamson Catania, Susan Larusse-Eckert, Melissa Barber Butson, Malia Rumbaugh, Michelle N. Strecker, J. Scott Roberts, Wylie Burke, Richard Mayeux, Thomas Bird

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Alzheimer disease is the most common cause of dementia. It occurs worldwide and affects all ethnic groups. The incidence of Alzheimer disease is increasing due, in part, to increased life expectancy and the aging baby boomer generation. The average lifetime risk of developing Alzheimer disease is 10-12%. This risk at least doubles with the presence of a first-degree relative with the disorder. Despite its limited utility, patients express concern over their risk and, in some instances, request testing. Furthermore, research has demonstrated that testing individuals for apolipoprotein E can be valuable and safe in certain contexts. However, because of the complicated genetic nature of the disorder, few clinicians are prepared to address the genetic risks of Alzheimer disease with their patients. Given the increased awareness in family history thanks to family history campaigns, the increasing incidence of Alzheimer disease, and the availability of direct to consumer testing, patient requests for information is increasing. This practice guideline provides clinicians with a framework for assessing their patients genetic risk for Alzheimer disease, identifying which individuals may benefit from genetic testing, and providing the key elements of genetic counseling for AD.

Original languageEnglish
Pages (from-to)597-605
Number of pages9
JournalGenetics in Medicine
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Genetic Counseling
Genetic Testing
Practice Guidelines
Alzheimer Disease
Joints
Inborn Genetic Diseases
Incidence
Apolipoproteins E
Life Expectancy
Ethnic Groups
Dementia
Counselors
Research

Keywords

  • Alzheimer disease
  • dementia
  • genetic counseling
  • genetic testing
  • guideline

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Genetic counseling and testing for Alzheimer disease : Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. / Goldman, Jill S.; Hahn, Susan E.; Catania, Jennifer Williamson; Larusse-Eckert, Susan; Butson, Melissa Barber; Rumbaugh, Malia; Strecker, Michelle N.; Roberts, J. Scott; Burke, Wylie; Mayeux, Richard; Bird, Thomas.

In: Genetics in Medicine, Vol. 13, No. 6, 01.06.2011, p. 597-605.

Research output: Contribution to journalArticle

Goldman, JS, Hahn, SE, Catania, JW, Larusse-Eckert, S, Butson, MB, Rumbaugh, M, Strecker, MN, Roberts, JS, Burke, W, Mayeux, R & Bird, T 2011, 'Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors', Genetics in Medicine, vol. 13, no. 6, pp. 597-605. https://doi.org/10.1097/GIM.0b013e31821d69b8
Goldman, Jill S. ; Hahn, Susan E. ; Catania, Jennifer Williamson ; Larusse-Eckert, Susan ; Butson, Melissa Barber ; Rumbaugh, Malia ; Strecker, Michelle N. ; Roberts, J. Scott ; Burke, Wylie ; Mayeux, Richard ; Bird, Thomas. / Genetic counseling and testing for Alzheimer disease : Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. In: Genetics in Medicine. 2011 ; Vol. 13, No. 6. pp. 597-605.
@article{86aa5cf9439b489ca53cb92fb1a069d9,
title = "Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors",
abstract = "Alzheimer disease is the most common cause of dementia. It occurs worldwide and affects all ethnic groups. The incidence of Alzheimer disease is increasing due, in part, to increased life expectancy and the aging baby boomer generation. The average lifetime risk of developing Alzheimer disease is 10-12{\%}. This risk at least doubles with the presence of a first-degree relative with the disorder. Despite its limited utility, patients express concern over their risk and, in some instances, request testing. Furthermore, research has demonstrated that testing individuals for apolipoprotein E can be valuable and safe in certain contexts. However, because of the complicated genetic nature of the disorder, few clinicians are prepared to address the genetic risks of Alzheimer disease with their patients. Given the increased awareness in family history thanks to family history campaigns, the increasing incidence of Alzheimer disease, and the availability of direct to consumer testing, patient requests for information is increasing. This practice guideline provides clinicians with a framework for assessing their patients genetic risk for Alzheimer disease, identifying which individuals may benefit from genetic testing, and providing the key elements of genetic counseling for AD.",
keywords = "Alzheimer disease, dementia, genetic counseling, genetic testing, guideline",
author = "Goldman, {Jill S.} and Hahn, {Susan E.} and Catania, {Jennifer Williamson} and Susan Larusse-Eckert and Butson, {Melissa Barber} and Malia Rumbaugh and Strecker, {Michelle N.} and Roberts, {J. Scott} and Wylie Burke and Richard Mayeux and Thomas Bird",
year = "2011",
month = "6",
day = "1",
doi = "10.1097/GIM.0b013e31821d69b8",
language = "English",
volume = "13",
pages = "597--605",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Genetic counseling and testing for Alzheimer disease

T2 - Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

AU - Goldman, Jill S.

AU - Hahn, Susan E.

AU - Catania, Jennifer Williamson

AU - Larusse-Eckert, Susan

AU - Butson, Melissa Barber

AU - Rumbaugh, Malia

AU - Strecker, Michelle N.

AU - Roberts, J. Scott

AU - Burke, Wylie

AU - Mayeux, Richard

AU - Bird, Thomas

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Alzheimer disease is the most common cause of dementia. It occurs worldwide and affects all ethnic groups. The incidence of Alzheimer disease is increasing due, in part, to increased life expectancy and the aging baby boomer generation. The average lifetime risk of developing Alzheimer disease is 10-12%. This risk at least doubles with the presence of a first-degree relative with the disorder. Despite its limited utility, patients express concern over their risk and, in some instances, request testing. Furthermore, research has demonstrated that testing individuals for apolipoprotein E can be valuable and safe in certain contexts. However, because of the complicated genetic nature of the disorder, few clinicians are prepared to address the genetic risks of Alzheimer disease with their patients. Given the increased awareness in family history thanks to family history campaigns, the increasing incidence of Alzheimer disease, and the availability of direct to consumer testing, patient requests for information is increasing. This practice guideline provides clinicians with a framework for assessing their patients genetic risk for Alzheimer disease, identifying which individuals may benefit from genetic testing, and providing the key elements of genetic counseling for AD.

AB - Alzheimer disease is the most common cause of dementia. It occurs worldwide and affects all ethnic groups. The incidence of Alzheimer disease is increasing due, in part, to increased life expectancy and the aging baby boomer generation. The average lifetime risk of developing Alzheimer disease is 10-12%. This risk at least doubles with the presence of a first-degree relative with the disorder. Despite its limited utility, patients express concern over their risk and, in some instances, request testing. Furthermore, research has demonstrated that testing individuals for apolipoprotein E can be valuable and safe in certain contexts. However, because of the complicated genetic nature of the disorder, few clinicians are prepared to address the genetic risks of Alzheimer disease with their patients. Given the increased awareness in family history thanks to family history campaigns, the increasing incidence of Alzheimer disease, and the availability of direct to consumer testing, patient requests for information is increasing. This practice guideline provides clinicians with a framework for assessing their patients genetic risk for Alzheimer disease, identifying which individuals may benefit from genetic testing, and providing the key elements of genetic counseling for AD.

KW - Alzheimer disease

KW - dementia

KW - genetic counseling

KW - genetic testing

KW - guideline

UR - http://www.scopus.com/inward/record.url?scp=79959193198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959193198&partnerID=8YFLogxK

U2 - 10.1097/GIM.0b013e31821d69b8

DO - 10.1097/GIM.0b013e31821d69b8

M3 - Article

C2 - 21577118

AN - SCOPUS:79959193198

VL - 13

SP - 597

EP - 605

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 6

ER -